Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WGCNA and machine learning identify AURKA, CDK1, and other hub genes associated with immune infiltration as therapeutic targets in GIST: An integrative bioinformatics analysis. | Medicine (Baltimore) | 2026 | 41496017 | PubTator, text mining | PubMed |
| BUB1 and CCNB2 mediate cell cycle and inflammation, influencing the progression of oral squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2026 | 41151687 | PubTator, text mining | PubMed |
| Action mechanisms of progesterone in managing bone loss in periodontitis: An in vitro study. | Arch Oral Biol | 2026 | 41138344 | PubTator, text mining | PubMed |
| PTTG1 as a common promising target for PCOS, Ovarian Cancer, and Major Depressive Disorder patients. | Comput Biol Chem | 2026 | 40925190 | PubTator, text mining | PubMed |
| Hypoxia Triggers ALYREF-Mediated m5C Methylation of KIF20A to Activate KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells. | Kaohsiung J Med Sci | 2026 | 40914946 | PubTator, text mining | PubMed |
| Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis. | Curr Med Chem | 2026 | 40676798 | PubTator, text mining | PubMed |
In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach. | Arch Iran Med | 2025 | 41852002 | PubTator, text mining | PubMed |
| BUB1 promotes lung adenocarcinoma progression by regulating STAT3/GPX4-mediated ferroptosis. | Front Oncol | 2025 | 41704471 | PubTator, text mining | PubMed |
| Transcriptomics driven identification of hub gene miRNA interactions for biomarker and therapeutic target discovery in gynecological cancers. | Front Oncol | 2025 | 41561741 | PubTator, text mining | PubMed |
| Expression and clinical significance of BUB1 in esophageal cancer. | Am J Transl Res | 2025 | 41552303 | PubTator, text mining | PubMed |
| Meta-Analysis and Experimental Studies Reveal Mitotic Network Activity Index (MNAI) as Breast Cancer Metastasis and Treatment Biomarker. | Life (Basel) | 2025 | 41465869 | PubTator, text mining | PubMed |
| Identification of key candidate genes for ovarian cancer using integrated statistical and machine learning approaches. | Brief Bioinform | 2025 | 41405958 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| hsa-let-7b-5p-associated BUB1/TMPO-AS1 ceRNA axis identified as a potential biomarker in lung adenocarcinoma. | Cell Div | 2025 | 41398961 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer. | Altern Ther Health Med | 2025 | 41289369 | PubTator, text mining | PubMed |
| Integrated analysis reveals survival-related genes promoting cholangiocarcinoma progression via G2/M cell cycle, with validation of cyclin B1 in tumor proliferation. | Sci Rep | 2025 | 41272097 | PubTator, text mining | PubMed |
| Nitidine chloride inhibits colorectal cancer by targeting BUB1: mechanistic insights from molecular dynamics simulation, spatial transcriptomics, and single-cell RNA sequencing. | BMC Gastroenterol | 2025 | 41257608 | PubTator, text mining | PubMed |
| Development and validation of a novel signature to predict the survival and affect the immune microenvironment of esophageal squamous cell carcinoma: epigenetic-related genes. | Front Immunol | 2025 | 41208974 | PubTator, text mining | PubMed |
| HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma. | World J Surg Oncol | 2025 | 41184881 | PubTator, text mining | PubMed |
| Exploring the carcinogenic potential of bisphenol A in lung adenocarcinoma: molecular mechanisms, key gene insights, and immune microenvironment impacts. | Front Immunol | 2025 | 41181148 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=4